Last edition
News about
Kiora Receives Grant from CRF for Clinical Trial Endpoints for Inherited Retinal Diseases
Kiora Pharmaceuticals has secured grant funding from the Choroideremia Research Foundation (CRF) in support of validating functional vision assessments for patients with profound blindness.
Granules India Unit V Facility Completes US FDA Inspection with Zero 483 Observations
Granules India Ltd. has announced that the company’s Unit V facility has completed the US Food and Drug Administration (FDA) inspection between April 8-12, 2024, resulting in zero 483 observations.
FDA Approves New Administration Options for XCOPRI to Address Needs of Patients with Seizures
The newly approved administration options allow XCOPRI tablets to be crushed and mixed with water, providing patients with additional flexibility in medication administration.
Asahi Kasei Bioprocess and Axolabs Forge Alliance to Propel Oligonucleotide Therapeutics
Oligonucleotide therapies offer a targeted approach to treating diseases by modulating gene expression, splicing, and protein production.
Awshad Rolls Out Brain-Boosting Nutritional Supplement Myndshroom
Awshad, a pioneering medical cannabis wellness startup, has rolled out its latest innovation, Myndshroom.
Thermo Fisher Introduces CTS OpTmizer One SFM to Boost Cell Therapy Manufacturing
Thermo Fisher Scientific has introduced the Gibco CTS OpTmizer One Serum-Free Medium (CTS OpTmizer One SFM).
The overall long-term safety results were consistent with the known safety profile of atogepant in chronic and episodic migraine, and no new safety signals were identified.
SII Joins Hands with Univercells to Make Personalized Oncology Affordable
The new therapies are developed using genetic material extracted from the patient’s tumors, a process which is both time-consuming, and expensive.
Telix Pharmaceuticals Completes Acquisition of ARTMS
Telix Pharmaceuticals Ltd. has completed the acquisition of ARTMS Inc.
<br />
Syntekabio to Showcase its AI Drug Discovery Tech at Bio-IT World Expo
Syntekabio, a global artificial intelligence (AI) drug discovery pioneer, has announced its participation at the upcoming Bio-IT World Conference & Expo.
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy